This result aligns with prior literature on miR-129’s role as a tumor suppressor, where it modulates targets such as HMGB1, BCL2, and thymidylate synthase, which are critical in cell proliferation, apoptosis, and DNA synthesis. The gene discussed is HMGB1; the disease is neoplasm.